文献速递细胞病理与分子病理神经与头颈病理

甲状腺影像报告和数据系统(TI-RADS)评分用于亚厘米甲状腺结节评估

Use of the thyroid imaging, reporting, and data system (TI-RADS) scoring system for the evaluation of subcentimeter thyroid nodules.
PubMed 文献 · Cancer Cytopathol · 2018-05-07

该回顾性研究分析了18个月内1491个甲状腺细针穿刺(FNA)结节,其中61个(4%)为亚厘米结节。TI-RADS高评分(4-5)与甲状腺乳头状癌(PTC)风险相关,低评分(1-2)无PTC,提示TI-RADS可用于亚厘米结节恶性风险评估,但需更大样本验证活检必要性。

要点

  • 亚厘米结节FNA常见原因包括较大伴发结节、癌症史或可疑超声特征。
  • TI-RADS高评分(4-5)结节中PTC占29.4%,低评分(1-2)为0%(P<.01)。
  • TI-RADS高/中评分结节中PTC/AUS/FLUS占32%,低评分为0%(P<.01)。

核心结论

  • TI-RADS评分系统可成功用于评估亚厘米甲状腺结节的恶性风险。
  • TI-RADS高评分亚厘米结节是否需活检尚需更大规模研究确定。

研究设计与样本

  • 回顾性图表审查,连续纳入18个月(2016-2017)1157例患者共1491个甲状腺FNA结节。

主要发现

  • FNA诊断:良性69%(42/61),PTC 10%(6/61),AUS/FLUS 15%(9/61),不满意/无诊断7%(4/61)。
  • 所有尺寸结节的无诊断率为3%,亚厘米结节为7%。
  • TI-RADS高评分(4-5)结节中PTC占29.4%,低评分(1-2)中PTC占0%(P<.01)。
  • TI-RADS高/中评分(3和4-5)结节中PTC/AUS/FLUS占32%,低评分中为0%(P<.01)。

关键数值与推荐

  • TI-RADS高评分(4-5)提示PTC风险29.4%,低评分(1-2)PTC风险0%(P<.01)。
  • TI-RADS高/中评分(3和4-5)提示PTC/AUS/FLUS风险32%,低评分风险0%(P<.01)。

临床怎么用

  • 对亚厘米甲状腺结节可应用TI-RADS评分辅助评估恶性风险。
  • TI-RADS低评分(1-2)亚厘米结节恶性风险低,或可避免不必要的FNA。
  • TI-RADS高评分(4-5)亚厘米结节需谨慎评估,活检指征待进一步研究。

局限性

  • 回顾性研究,亚厘米结节样本量小(61个)。
  • 需更大规模研究验证TI-RADS高评分亚厘米结节活检的必要性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The American Thyroid Association (ATA) recommends fine-needle aspiration (FNA) biopsy of nodules measuring >1.5 cm with low-suspicion sonographic patterns or >1.0 cm with high/intermediate-suspicion features. Routine biopsy of nodules <1 cm is not recommended. However, despite these recommendations, subcentimeter nodules are often referred for FNA biopsy. METHODS: This was a retrospective chart review of consecutive thyroid FNAs during an 18-month period (1157 patients, 1491 nodules, 2016-2017) to evaluate age, sex, medical history, diagnoses, and follow-up. Radiographic information was used to identify 61 subcentimeter nodules (4%) from 57 patients. Ultrasound studies were re-evaluated using criteria according to the American College of Radiology Thyroid Imaging, Reporting, and Data System (TI-RADS). RESULTS: Reported reasons for biopsy included a larger companion nodule (44%), a personal or family history of cancer (26%), or a suspicious sonogram, including calcification and/or irregular contours (16%). FNA diagnoses included: 69% benign (42 of 61 nodules), 10% papillary thyroid carcinoma (PTC) (6 of 61 nodules), and 15% atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) (9 of 61 nodules). Seven percent of nodules were unsatisfactory/nondiagnostic (4 of 61 nodules) compared with a 3% nondiagnostic rate for all sized nodules. Fifty-one nodules had an ultrasound available for re-review using the TI-RADS scoring system. A high TI-RADS score (4-5) was indicative of PTC in 29.4% of nodules. A low TI-RADS score (1-2) was indicative of PTC in 0% of nodules (P < .01). High and intermediate TI-RADS scores (3 and 4-5, respectively) were indicative of PTC/AUS/FLUS in 32% of nodules compared with 0% in those with low TI-RADS scores (P < .01). CONCLUSIONS: The current results demonstrate successful use of the TI-RADS scoring system in evaluation of the risk of malignancy in subcentimeter nodules. Larger studies will be necessary to determine whether biopsy is warranted for TI-RADS high-subcentimeter nodules. Cancer Cytopathol 2018. © 2018 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Weiss VL, Andreotti RF, Ely KA, et al. Use of the thyroid imaging, reporting, and data system (TI-RADS) scoring system for the evaluation of subcentimeter thyroid nodules. Cancer Cytopathol. 2018. PMID: 29733503. doi:10.1002/cncy.22015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。